Search results
Eli Lilly Surges After Weight-Loss Drug Obliterates Sales Views
Investor's Business Daily· 6 days agoIn the March quarter, Zepbound brought in $517.4 million in sales, beating forecasts for $373...
Is Eli Lilly Stock A Buy After Weight-Loss Drug Crushes Quarterly Sales Forecasts?
Investor's Business Daily· 6 days agoZepbound is made from tirzepatide, the same chemical backbone behind diabetes drug...
Eli Lilly's Weight-Loss Drug Still Going Strong, Boosts Annual Forecast
Benzinga via Yahoo Finance· 6 days agoThe volume increase was primarily driven by growth from Mounjaro, Zepbound, Verzenio, and Jardiance,...
Chasing Novo and Lilly: The obesity drugs that could challenge Wegovy and Zepbound
BioPharma Dive via Yahoo Finance· 7 days agoLarge and small drugmakers are vying for a piece of what analysts view as one of the biggest market...
Does Medicare cover Ozempic? - WTOP News
WTOP Washington· 5 days agoAs the overall population ages, there is a growing prevalence of diabetes among adults ages 65 and older. In fact, about 16.5 million people in this age...
Why a legal fight against the manufacturers of Ozempic, Mounjaro, and other diabetes and weight-loss...
Philly.com· 5 days agoThe patients live all over the country, but the lawsuits that play out in a Philadelphia courtroom...
Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised
Zacks via Yahoo Finance· 6 days agoEli Lilly (LLY) beats first-quarter estimates for earnings but misses the same for sales. It raises...
Lilly sees quarterly profit jump 67% on demand for new weight-loss drugs - Indianapolis Business...
Indianapolis Business Journal· 7 days agoEli Lilly and Co. said Tuesday that “exceptionally strong demand” for diabetes drugs Mounjaro and ...
Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes
Reuters via Yahoo News· 6 days agoIn 2023, 50% of new patients suffering from type 2 diabetes began treatment with a reimbursed GLP-1...
Eli Lilly’s stock jumps as first-quarter profit tops estimates amid strong sales of Mounjaro,...
Market Watch· 6 days agoEli Lilly & Co. shares gained 7% premarket on Tuesday after the company reported first-quarter...